Identification of T cell epitopes of Trypanosoma cruzi antigen using HLA-B transgenic mice
Identification of T cell epitopes of Trypanosoma cruzi antigen using HLA-B transgenic mice
批准号:
06807025
负责人:
HIRAYAMA Kenji
金额:
$1.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Analysis of the protective immunity against infection with Trypanosoma cruzi (TC) in the experimental animalmodel using a HLA-B35 transgenic mouse (HLA-B35-TG).CD8 positive cytotoxic T cells are known to be major effector cells to kill the TC infected host cells. Those T cells recognize the invaders antigen with their own HLA-class lmolecules. Using chronically infected HLA-B35-TG,we tried to identify the T cell epitopes that HLA molecule presents to the CD8 cytotoxic T cells. Using the information of the binding motif of HLA-B35, we selected and synthesized 61 different peptides (8mer to 10 mer) from TC cysteine protease. After the binding assay, 5 peptides were chosen for in vitro stimulation experiments. Two months after the infection with TC,HLA-B35-TG mice were sacrificed to get the splenocytes. One million cells in 1 ml of culture medium were incubated with 10muM of each peptide and 30Units of IL-2. Ten dyas later, re-stimulation was done by adding irradiated peptide pulsed autologous splenocytes and IL-2. Totally 2wks. later, the viable cells (T cells) were examined for their cytotoxic activity against peptide pulsed target cells (HLA-B35 Transfectant) by Chromium 51 release assay. None of the peptides stimulated the cytotoxic T cells. though we repeated the experiments twice. Main reasons why there were no effective stimulation were considered as follows.(1) HLA-B35 might not be ideal for the analysis of immune response against the cysteine protease antigen due to row affintiy.(2) Human CD8 might have been essential to complete the HLA-peptide-T cell interaction.2. Search for the major T cell antigens recognized by human T cells from the patients in the endemic area. We have produced T cell clones reactive to epimastigote antigen. Using a T cell clone, 55KDa protein were purified whose molecular weight is almost the same as the cysteine protease. The amino acid sequencing are now on going study.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kenji Hirayama: "T-Lymphoproliferative response of the patients with Chagas'desease to epimastigote antigen of T. curuzi in GUATEMALA" Jpn. J. Trop. Med. Hyg.23(1),. 65 (1995)
Kenji Hirayama:“危地马拉恰加斯病患者对 T. curuzi 上鞭毛体抗原的 T 淋巴细胞增殖反应”Jpn。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kenji Hirayama: "T-Lymphoproliferative response of the patients with Chagas' desease to epimastigote antigen of T. curuzi in GUATEMALA" Jpn. J. Trop. Med. Hyg.23(1). 65 (1995)
Kenji Hirayama:“危地马拉恰加斯病患者对 T. curuzi 上鞭毛体抗原的 T 淋巴细胞增殖反应”Jpn。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Maria Paula de Leon: "Analysis of polymorphism of the gene encoding Cysteine Protease from different strains of Trypanosoma cruzi" Jpn. J. Trop. Med. Hyg.(in press).
Maria Paula de Leon:“来自不同克氏锥虫菌株的编码半胱氨酸蛋白酶的基因多态性分析”Jpn。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Maria Paula de Leon: "Analysis of polymorphism of the gene encoding Cysteine Protease from different strains of Trypanosoma cruzi" Jpn.J.Trop.Med.Hyg. (in press).
Maria Paula de Leon:“来自不同克氏锥虫菌株的编码半胱氨酸蛋白酶的基因多态性分析”Jpn.J.Trop.Med.Hyg。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kenji Hirayama: "T-Lympho-proliferative response of the patients with Chagas' disease to epimastigote antigen of T.cruzi in Guatemala" Jpn.J.Trop.Med.Hyg. 23(1). 65 (1995)
Kenji Hirayama:“危地马拉恰加斯病患者对克氏锥虫上鞭毛体抗原的 T 淋巴细胞增殖反应”Jpn.J.Trop.Med.Hyg。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 8 条
Antigenic variation can change T cell immunity in malaria?
-
批准号:17H04072
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.4万
-
财政年份:2017
-
负责人:HIRAYAMA Kenji
-
依托单位:
Animal model for the treatment of Chronic Chagas Disease using the combination of drug and vaccine
-
批准号:23590486
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:HIRAYAMA Kenji
-
依托单位:
Host and parasite genetic factors that influence the reactivity to Benznidazol treatment of the peadiatric chronic Chagas patients in Bolivia
-
批准号:23256003
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$29.2万
-
财政年份:2011
-
负责人:HIRAYAMA Kenji
-
依托单位:
Immunogenetic analysis of pathogenesis of Chagas Disease in South America.
-
批准号:15406016
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.51万
-
财政年份:2003
-
负责人:HIRAYAMA Kenji
-
依托单位:
Pathogenic factors for the development of chronic Chagas disease in Latin America
-
批准号:12376001
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$26.53万
-
财政年份:2000
-
负责人:HIRAYAMA Kenji
-
依托单位:
Immunogenetic analysis of schistosomiasis japonica in China
-
批准号:10044317
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$3.2万
-
财政年份:1998
-
负责人:HIRAYAMA Kenji
-
依托单位:
Genetic susceprtibity to acute or chronic schistosomiasis japonica
-
批准号:09470071
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.32万
-
财政年份:1997
-
负责人:HIRAYAMA Kenji
-
依托单位:
IMMNOGENETIC ANALYSIS OF SCHISTOSOMIASIS JAPONICA IN CHINA
-
批准号:08044316
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$3.07万
-
财政年份:1996
-
负责人:HIRAYAMA Kenji
-
依托单位:
Immunogenetic analysis of post-schistosomal liver disease in China
-
批准号:07044290
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$1.47万
-
财政年份:1995
-
负责人:HIRAYAMA Kenji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
LILRB2/HLA-G免疫抑制轴在胶质瘤干细胞免疫逃逸中的作用及其与STAT3信号通路的交互调控机制研究
-
批准号:2026JJ80459
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王彪
-
依托单位:
HLA-DR+中性粒细胞调控儿童噬血细胞综合征细胞因子风暴的机制及临床价值研究
-
批准号:2026JJ81611
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘灿
-
依托单位:
HLA-B*13:01介导阿苯达唑肝损伤的毒理机制及构效关系研究
-
批准号:2026JJ50638
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:饶泰
-
依托单位:
肝内胆管细胞癌中TREM2+巨噬细胞通过增强HLA-C/FAM3C信号通路依赖性淋巴管生成促进肿瘤转移的机制研究
-
批准号:QN25H160111
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:万喆
-
依托单位:
HLA-B27通过肠道菌群失衡致炎促AS发展的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:郑海雅
-
依托单位:
三阴性乳腺癌HLA-I和HLA-II限制性T细胞表位鉴定与免疫治疗
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邵营宽
-
依托单位:
EBV高危亚型编码的BALF2-HR蛋白上调HLA-II类分子促进鼻咽癌免疫逃逸的机制研究
-
批准号:2025JJ60152
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:葛军尚
-
依托单位:
HLA-C 提高CAR-T 细胞治疗急性淋巴细胞白血病效能及机制的探讨
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:张诚
-
依托单位:
HLA-G在胃癌发生发展中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:章霞
-
依托单位:
血小板通过上调结肠癌细胞 HLA-F 表达促进
结肠癌发展的分子机制
-
批准号:Q24H160122
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:陈欣
-
依托单位: